HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eseng Lai Selected Research

prostaglandin D2 receptor

11/2009Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.
9/2009Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiency.
5/2009Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
4/2009Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
11/2008Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eseng Lai Research Topics

Disease

15Dyslipidemias (Dyslipidemia)
09/2015 - 04/2006
15Flushing
08/2012 - 04/2006
11Type 2 Diabetes Mellitus (MODY)
12/2019 - 01/2017
5Hypoglycemia (Reactive Hypoglycemia)
04/2018 - 08/2017
3Heart Failure
11/2017 - 01/2010
2COVID-19
08/2022 - 01/2022
2Chronic Kidney Failure (Chronic Renal Failure)
12/2019 - 06/2017
2Body Weight (Weight, Body)
11/2017 - 11/2017
2Hepatic Insufficiency
11/2014 - 03/2011
2Renal Insufficiency (Renal Failure)
11/2014 - 09/2009
1Vesicular Stomatitis
08/2022
1Measles
01/2022
1Respiratory Syncytial Virus Infections
11/2021
1Infections
11/2021
1Disease Progression
11/2017
1Myocardial Infarction
11/2017
1Stroke (Strokes)
11/2017
1Weight Gain
10/2017
1Weight Loss (Weight Reduction)
10/2017
1Hypercholesterolemia
01/2014
1Obesity
09/2012
1Allergic Rhinitis
11/2009
1Asthma (Bronchial Asthma)
11/2009
1Rhinitis
11/2009
1Pruritus (Itching)
04/2009

Drug/Important Bio-Agent (IBA)

17Niacin (Nicotinic Acid)FDA LinkGeneric
08/2012 - 04/2006
16MK-0524IBA
01/2014 - 04/2006
112- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
12/2019 - 01/2017
9ProstaglandinsIBA
08/2012 - 07/2007
5Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017 - 01/2017
5prostaglandin D2 receptorIBA
11/2009 - 11/2008
4Metformin (Glucophage)FDA LinkGeneric
11/2017 - 01/2017
4LipidsIBA
09/2015 - 10/2008
2COVID-19 VaccinesIBA
08/2022 - 01/2022
2glimepiride (Amarel)FDA LinkGeneric
11/2017 - 10/2017
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2017 - 08/2017
2Sitagliptin Phosphate (Januvia)FDA Link
11/2017 - 01/2017
2Pharmaceutical PreparationsIBA
08/2017 - 11/2014
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2014 - 04/2009
2rolofyllineIBA
01/2010 - 01/2010
2Adenosine A1 ReceptorIBA
01/2010 - 01/2010
2Prostaglandin D2IBA
04/2009 - 11/2008
1VaccinesIBA
08/2022
1Glycoproteins (Glycoprotein)IBA
11/2021
1MK-1654IBA
11/2021
1Monoclonal AntibodiesIBA
11/2021
1Neutralizing AntibodiesIBA
11/2021
1omega-Chloroacetophenone (Mace)IBA
11/2017
1Insulin (Novolin)FDA Link
06/2017
1Glipizide (Glucotrol)FDA LinkGeneric
06/2017
1anacetrapibIBA
11/2014
1Adenosine Diphosphate (ADP)IBA
01/2014
1Clopidogrel (Plavix)FDA Link
01/2014
1CollagenIBA
01/2014
11,1,1- trifluoro- 2- (4- (1H- pyrazol- 1- yl)phenyl)- 3- (4- ((1- (trifluoromethyl)cyclopropyl)methyl)- 1H- imidazol- 2- yl)propan- 2- olIBA
09/2012
1Bombesin Receptors (Bombesin Receptor)IBA
09/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2012
1Prostaglandins DIBA
12/2009
1AllergensIBA
11/2009
1montelukast (Singulair)FDA Link
11/2009
1Cetirizine (Zyrtec)FDA LinkGeneric
11/2009
1CreatinineIBA
09/2009
1GlucuronidesIBA
09/2009
1TabletsIBA
11/2008
1Nonesterified Fatty Acids (NEFA)IBA
10/2008
1Triglycerides (Triacylglycerol)IBA
10/2008
1HDL CholesterolIBA
10/2008
13- (1H- tetrazol- 5- yl)- 1,4,5,6- tetrahydrocyclopentapyrazoleIBA
10/2008
1LDL CholesterolIBA
10/2008
1Acetic Acid (Vinegar)FDA LinkGeneric
07/2007

Therapy/Procedure

5Glycemic Control
04/2018 - 08/2017
5Therapeutics
10/2017 - 11/2008
1Intramuscular Injections
01/2022